OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 48 filers reported holding OVID THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $239,389 | +17.1% | 62,341 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $204,478 | +24.3% | 62,341 | -2.2% | 0.00% | 0.0% |
| Q1 2023 | $164,452 | -46.8% | 63,741 | -61.6% | 0.00% | -50.0% |
| Q4 2022 | $308,837 | -65.1% | 166,041 | -24.6% | 0.00% | -71.4% |
| Q1 2021 | $886,000 | +918.4% | 220,357 | +482.3% | 0.01% | +600.0% |
| Q4 2020 | $87,000 | -62.8% | 37,843 | -7.1% | 0.00% | -50.0% |
| Q3 2020 | $234,000 | +22.5% | 40,717 | -48.5% | 0.00% | -33.3% |
| Q4 2018 | $191,000 | -1.0% | 79,094 | +131.9% | 0.00% | 0.0% |
| Q3 2018 | $193,000 | – | 34,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,380,346 | $3,516 | 18.08% |
| Madison Avenue Partners, LP | 3,104,603 | $8,009,876 | 1.72% |
| BVF INC/IL | 6,851,051 | $17,675,712 | 0.65% |
| CHI Advisors LLC | 864,822 | $2,231,241 | 0.59% |
| EcoR1 Capital, LLC | 6,117,400 | $15,782,892 | 0.51% |
| Rubric Capital Management LP | 7,001,124 | $18,062,900 | 0.47% |
| Artal Group S.A. | 2,500,000 | $6,450 | 0.38% |
| Tejara Capital Ltd | 118,791 | $306,481 | 0.16% |
| DCF Advisers, LLC | 68,264 | $176,120 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 827,580 | $2,135,156 | 0.06% |